Involvement of aldose reductase in naphthalene cataract

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 1, 1998, Pages 193-197

  Lee, Alan Y W ^a   Chung, Stephen S M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; IMIRESTAT; NAPHTHALENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALDEHYDE REDUCTASE; ANIMALS; CATARACT; CULTURE MEDIA; DISEASE PROGRESSION; ENZYME INHIBITORS; FLUORENES; HYDANTOINS; LENS, CRYSTALLINE; MICE; MICE, TRANSGENIC; NAPHTHOLS; ORGAN CULTURE TECHNIQUES;

EID: 0031964665     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. van Heyningen R, Pirie A. The metabolism of naphthalene and its toxic effect on the eye. Biochem J. 1967;102:842-852.
2. van Heyningen R, Pirie A. Naphthalene cataract in pigmented and albino rabbits. Exp Eye Res. 1976;22:393-394.
3. van Heyningen R. Naphthalene cataract in rats and rabbits: a resume. Exp Eye Res. 1979;28:435-439.
4. Rossa V, Pau H. Is the experimental naphthalene cataract a model for human senile cataract? Graefes Arch Clin Exp Ophthalmol. 1988;226:291-293.
5. Rossa V, Kluxen G. Toxic lenses-how they compare with senile cataracts. Dev Ophthalmol. 1989;17:165-168.
6. Xu GT, Zigler JS Jr, Lou MF. Establishment of a naphthalene cataract model in vitro. Exp Eye Res. 1992;54:73-81.
7. Hara A, Harada T, Nakagawa M, Matsuura K, Nakayama T, Sawada H. Isolation from pig lens of two proteins with dihydrodiol dehydrogenase and aldehyde reductase activities. Biochem J. 1989;264: 403-407.
8. Sato S. Aldose reductase: the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens. Invest Ophthalmol Vis Sci. 1993;34:3172-3178.
9. Tao RV, Takahashi Y, Kador PF. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat. Invest Ophthalmol Vis Sci. 1991;32:1630-1637.
10. Tao RV, Holleschau AM, Rathbun WB. Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes. Ophthalmic Res. 1991;23:272-283.
11. Griffin BW, McNatt LG, Chandler ML, York BM. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats. Metabolism. 1987;36:486-490.
12. Beyer Mears A, Cruz E. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes. 1985;34:15-21.
13. Simard Duquesne N, Greselin E, Gonzalez R, Dvornik D. Prevention of cataract development in severely galactosemic rats by the aldose reductase inhibitor, tolrestat. Proc Soc Exp Biol Med. 1985; 178:599-605.
14. Ao S, Shingu Y, Kikuchi C, et al. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat. Metabolism. 1991;40:77-87.
15. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res. 1974;19:577-582.
16. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA. 1995;92:2780-2784.
17. Lou MF, Xu GT, Zigler S Jr, York BJ. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors. Curr Eye Res. 1996;15:423-432.
18. Sato S, Sugiyama K, Carper D. Aldose reductase as dihydrodiol dehydrogenase - naphthoquinone formation by rat lens aldose reductase. In: Weiner H. et al. eds. Enzymology and Molecular Biology of Carbonyl Metabolism. 6. New York: Plenum Press; 1996:499-505.
19. Reddy VN. Metabolism of glutathione in the lens. Exp Eye Res. 1971;11:310-328.
20. Rees JR, Pirie A. Possible reactions of 1,2-naphthaquinone in the eye. Biochem J. 1967;102:853-863.
21. Rathbun WB, Holleschau AM, Murray DL, Buchanan A, Sawaguchi S, Tao RV. Glutathione synthesis and glutathione redox pathways in naphthalene cataract of the rat. Curr Eye Res. 1990;9:45-53.